UK infected blood scandal: £1bn compensation boost announced for victims
The UK government has announced a £1 billion increase to the infected blood compensation scheme, marking a significant development in one of the most devastating public health failures in British history.
The additional funding will raise compensation payments for thousands affected by the UK infected blood scandal, including new and increased awards for victims and their families. The move comes amid ongoing criticism over delays, complexity, and concerns that previous payouts did not go far enough.
A historic NHS scandal
The infected blood scandal—widely described as the worst treatment disaster in NHS history—saw more than 30,000 people across the UK infected with HIV, hepatitis B, hepatitis C, or multiple viruses through contaminated blood products before 1996. More than 3,000 people have since died.
The final report of the public inquiry, published in 2024, exposed widespread failings in the healthcare system and prompted the creation of a national compensation scheme. However, the rollout of payments has been marred by controversy, with victims raising concerns over eligibility criteria, payment levels, and a complicated application process.
Increased payments for victims and families
Under the latest reforms, compensation awards will increase for both infected individuals and those affected indirectly, including relatives.
A key change includes enhanced payments for victims of unethical medical research, particularly former pupils at Treloar’s College in Hampshire, where haemophiliac children were subjected to experimental treatments without informed consent.
Payments for these individuals will rise from £25,000 to £60,000, while new awards of £45,000 will be introduced for those treated elsewhere during childhood. Compensation for adults affected by similar treatments will also increase, with payments tripled to £30,000.
In addition, individuals whose careers were disrupted by infection may receive an extra £60,000 lump sum, reflecting lost earning potential.
Mixed reaction from victims and campaigners
Despite the increased funding, reaction from the infected blood community has been mixed. Many have welcomed the government’s acknowledgment of their suffering, but questions remain over whether the compensation is sufficient.
Campaigners argue that no financial settlement can truly account for the lifelong impact of the scandal. Some victims have also expressed concern that certain health complications—particularly the long-term effects of hepatitis C treatment—have not been fully recognised.
Organisations including the Haemophilia Society and Hepatitis C Trust have called for further reforms, warning that the scheme still falls short of delivering full justice.
Progress made—but challenges remain
As of early April 2026, over 3,200 compensation offers have been made, totalling more than £2.6 billion, with the majority accepted. However, campaigners continue to highlight the urgent need for faster payments and a more transparent process.
The government insists the latest changes demonstrate its commitment to supporting victims of the NHS infected blood scandal, but pressure is mounting to ensure the scheme is both fair and accessible.
